David Peritt

2.6k total citations
34 papers, 2.1k citations indexed

About

David Peritt is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, David Peritt has authored 34 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in David Peritt's work include Immune Cell Function and Interaction (16 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (8 papers). David Peritt is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (8 papers). David Peritt collaborates with scholars based in United States, Israel and Italy. David Peritt's co-authors include Giorgio Trinchieri, Miguel Aste-Amézaga, Louise C. Showe, Giorgia Gri, Susan Robertson, Franca Gerosa, Thomas Schwarz, David J. Shealy, Agatha Schwarz and Akira Maeda and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

David Peritt

34 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Peritt United States 19 1.5k 325 279 251 239 34 2.1k
David Sehy United States 8 2.1k 1.4× 564 1.7× 115 0.4× 354 1.4× 221 0.9× 14 2.8k
Richard J. Hocking United States 4 2.8k 1.9× 525 1.6× 157 0.6× 399 1.6× 320 1.3× 8 3.4k
Odile Djossou France 13 1.6k 1.1× 457 1.4× 144 0.5× 282 1.1× 195 0.8× 13 2.2k
Corinna F. Brereton Ireland 8 1.9k 1.3× 303 0.9× 133 0.5× 465 1.9× 215 0.9× 9 2.5k
Richard D. Garman United States 24 1.3k 0.9× 380 1.2× 139 0.5× 403 1.6× 142 0.6× 34 2.2k
M. Durm United States 9 1.2k 0.8× 231 0.7× 281 1.0× 236 0.9× 250 1.0× 9 1.7k
Arnold I. Levinson United States 27 1.2k 0.8× 128 0.4× 195 0.7× 320 1.3× 172 0.7× 89 2.4k
Bianca M. Wittig Germany 24 875 0.6× 211 0.6× 174 0.6× 459 1.8× 130 0.5× 60 1.9k
Sanae Fujino Japan 9 1.4k 0.9× 306 0.9× 122 0.4× 335 1.3× 272 1.1× 10 2.1k
S Tagawa Japan 16 901 0.6× 415 1.3× 489 1.8× 602 2.4× 417 1.7× 47 1.9k

Countries citing papers authored by David Peritt

Since Specialization
Citations

This map shows the geographic impact of David Peritt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Peritt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Peritt more than expected).

Fields of papers citing papers by David Peritt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Peritt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Peritt. The network helps show where David Peritt may publish in the future.

Co-authorship network of co-authors of David Peritt

This figure shows the co-authorship network connecting the top 25 collaborators of David Peritt. A scholar is included among the top collaborators of David Peritt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Peritt. David Peritt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carmona, Guillaume, Lauren E. Barney, Jared Allan Sewell, et al.. (2019). Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living TherapeuticsTM Products. Blood. 134(Supplement_1). 2065–2065. 7 indexed citations
2.
Gouty, Dominique, Xiaoyan Cai, Vijay Kumar, et al.. (2017). Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment. The AAPS Journal. 20(1). 25–25. 8 indexed citations
3.
Christie, M.G., David Peritt, Raul M. Torres, Theodore W. Randolph, & John F. Carpenter. (2015). The Role of Protein Excipient in Driving Antibody Responses to Erythropoietin. Journal of Pharmaceutical Sciences. 104(12). 4041–4055. 10 indexed citations
4.
Benson, Jacqueline, David Peritt, Bernard J. Scallon, et al.. (2011). Discovery and mechanism of ustekinumab. mAbs. 3(6). 535–545. 254 indexed citations
5.
Greinix, Hildegard, Gèrard Socié, Andrea Bacigalupo, et al.. (2006). Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplantation. 38(4). 265–273. 53 indexed citations
6.
Peritt, David. (2006). Potential Mechanisms of Photopheresis in Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 12(1). 7–12. 74 indexed citations
7.
Seideman, Jonathan & David Peritt. (2002). A novel monoclonal antibody screening method using the Luminex-100™ microsphere system. Journal of Immunological Methods. 267(2). 165–171. 59 indexed citations
8.
Peritt, David, Deborah Sesok‐Pizzini, Rob Roy MacGregor, et al.. (1999). C1.7 Antigen Expression on CD8+ T Cells Is Activation Dependent: Increased Proportion of C1.7+CD8+ T Cells in HIV-1-Infected Patients with Progressing Disease. The Journal of Immunology. 162(12). 7563–7568. 37 indexed citations
9.
Peritt, David, Susan Robertson, Giorgia Gri, et al.. (1998). Cutting Edge: Differentiation of Human NK Cells into NK1 and NK2 Subsets. The Journal of Immunology. 161(11). 5821–5824. 200 indexed citations
10.
Baumgart, Daniel C., et al.. (1998). Mechanisms of Intestinal Epithelial Cell Injury and Colitis in Interleukin 2 (IL2)-Deficient Mice. Cellular Immunology. 187(1). 52–66. 35 indexed citations
11.
Salhany, Kevin E., Michael D. Feldman, Marc J. Kahn, et al.. (1997). Hepatosplenic γδ T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Human Pathology. 28(6). 674–685. 55 indexed citations
12.
Gerosa, Franca, C Paganin, David Peritt, et al.. (1996). Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10.. The Journal of Experimental Medicine. 183(6). 2559–2569. 277 indexed citations
13.
Paganin, C, Franca Gerosa, David Peritt, et al.. (1996). Effect of Interleukin‐12 on the Cytokine Profile of Human CD4 and CD8 T‐Cell Clones. Annals of the New York Academy of Sciences. 795(1). 382–383. 3 indexed citations
14.
Trinchieri, Giorgio, David Peritt, & Franca Gerosa. (1996). Acute induction and priming for cytokine production in lymphocytes. Cytokine & Growth Factor Reviews. 7(2). 123–132. 26 indexed citations
15.
Showe, Louise C., Maria Wysocka, Bei Wang, et al.. (1996). Structure of the Mouse IL‐12R01 Chain and Regulation of Its Expression in BCG/LPS‐Treated Mice. Annals of the New York Academy of Sciences. 795(1). 413–415. 11 indexed citations
16.
Puré, Ellen, Robert L. Camp, David Peritt, et al.. (1995). Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.. The Journal of Experimental Medicine. 181(1). 55–62. 74 indexed citations
17.
Quill, Helen, et al.. (1994). Induction of interleukin 12 responsiveness is impaired in anergic T lymphocytes.. The Journal of Experimental Medicine. 179(3). 1065–1070. 22 indexed citations
18.
Barak, Vivian, et al.. (1993). In vivo anti inflammatory effects of the M20 IL-1 Inhibitor: I. Effects on acute inflammatory parameters. Biotherapy. 6(4). 263–270. 5 indexed citations
19.
Barak, V., et al.. (1993). In vivo anti-inflammatory effects of the M20 IL-1 Inhibitor: II. Effects on serum reactants. Biotherapy. 6(4). 271–277. 5 indexed citations
20.
Barak, Vivian, David Peritt, I. Flechner, et al.. (1992). The M20 IL-1 inhibitor prevents onset of adjuvant arthritis. Biotherapy. 4(4). 317–323. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Sehy Breakdown of academic impact, for papers by Richard J. Hocking Breakdown of academic impact, for papers by Odile Djossou Breakdown of academic impact, for papers by Corinna F. Brereton Breakdown of academic impact, for papers by Richard D. Garman Breakdown of academic impact, for papers by M. Durm Breakdown of academic impact, for papers by Arnold I. Levinson Breakdown of academic impact, for papers by Bianca M. Wittig Breakdown of academic impact, for papers by Sanae Fujino Breakdown of academic impact, for papers by S Tagawa
Rankless by CCL
2026